Back to calendar
Repligen Corporation (RGEN) Earnings
RGEN reports earnings on Tuesday, July 28, 2026
earnings report
July 28, 2026
Q2 2026
Est. EPS: $0.47
Actual EPS: $0.54
EPS surprise: 20.79%
Company overview
Market Cap$8.5B
PriceUSD 150.30
P/E165.46
EPS (TTM)0.91
52-week high175.77
52-week low100.99
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees2,000